Concepedia

Prognostic risk factors in advanced Hodgkin's lymphoma

Markus Loeffler, Michael Pfreundschuh, Dirk Hasenclever, Erhard Hiller, H Gerhartz, W. Wilmanns, R Rohloff, U. R�hl, G. K�hn, Roland J. Fuchs,

Annals of Hematology · 1988 · 45 citations · 9 references

DOI

Concepts

References

9

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

Vincent T. DeVita · Annals of Internal Medicine · 1970 · 1.4K citations

, , +17

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

Gianni Bonadonna, R Zucali, S. Monfardini et al. · Cancer · 1975 · 760 citations · Full text

, , +14

Twenty years of MOPP therapy for Hodgkin's disease.

Dan L. Longo, Robert C. Young, Margaret Wesley et al. · Journal of Clinical Oncology · 1986 · 439 citations

, , +17

Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's Disease

Gianni Bonadonna, Pinuccia Valagussa, Armando Santoro · Annals of Internal Medicine · 1986 · 365 citations

, , +9

Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.

Pfreundschuh Mg, Schoppe Wd, Roland J. Fuchs et al. · PubMed · 1987 · 61 citations

, , +15